Inflammation
|
Polystyrene particles |
202 nm and 535 nm |
|
[112] |
Unaltered/Carboxylated polystyrene nanoparticles |
20 nm, 44 nm, 500 nm, and 1000 nm |
|
[113,114] |
Carboxylated and amino-modified polystyrene particles |
120 nm |
Altered expression of scavenger receptors.
M2 cells increased IL-10 production.
Increased TGFβ1 (M1) and energy metabolism (M2).
|
[115] |
Unaltered polyethylene particles |
0.3 μm, 10 μm |
|
[117] |
Polyethylene particles from plastic prosthetic implants |
0.2 μm and 10 μm |
Induced the expression of TNFα, IL-1, and RANKL.
Resulted in periprosthetic bone resorption.
|
[121] |
|
|
[121,122,123] |
Polystyrene microplastics particles |
5 μm and 20 μm |
|
[125] |
Oxidative stress and apoptosis
|
Amine-modified polystyrene nanoparticles |
60 nm |
|
[126] |
Cationic polystyrene nanoparticles |
60 nm |
|
[127,128] |
|
Unaltered or functionalized polystyrene |
20 nm, 40 nm, 50 nm, and 100 nm |
|
[129,130,131,132] |
|
polyvinyl chloride (PVC) and poly (methyl methacrylate) (PMMA) |
120 nm, 140 nm |
|
[133] |
Metabolic homeostasis
|
Pristine and fluorescent polystyrene microplastics |
5 µm |
|
[134,135] |
Anionic carboxylated polystyrene nanoparticles |
20 nm |
Altered ion channel function and ionic homeostasis
Activated basolateral K+ channels.
Induced Cl− and HCO3− ion efflux.
|
[136] |
Polystyrene nanoparticles |
30 nm |
|
[137] |
Cationic polystyrene nanoparticles |
50 nm and 200 nm |
|
[138] |
Pristine polystyrene microparticles |
5 µm and 20 µm |
|
[125,139,140] |
Microplastics |
0.5 µm and 5 µm |
|
[135,141] |